🔗 Share this article

The top legal official in Texas Ken Paxton is taking legal action against the makers of Tylenol, asserting the corporations concealed potential risks that the medication presented to children's brain development.

The lawsuit arrives a month after President Donald Trump advocated an unverified association between consuming Tylenol - alternatively called paracetamol - while pregnant and autism in offspring.

Paxton is filing suit against J&J, which previously sold the drug, the sole analgesic approved for women during pregnancy, and the current manufacturer, which presently makes it.

In a declaration, he claimed they "misled consumers by gaining financially from suffering and marketing drugs ignoring the potential hazards."

Kenvue states there is no credible evidence linking acetaminophen to autism spectrum disorder.

"These companies deceived for years, knowingly endangering millions to increase profits," the attorney general, from the Republican party, said.

The company commented that it was "seriously troubled by the spread of false claims on the safety of paracetamol and the likely effects that could have on the health of US mothers and children."

On its online platform, the company also stated it had "consistently assessed the applicable studies and there is no credible data that indicates a proven link between using acetaminophen and autism spectrum disorder."

Associations speaking for doctors and medical practitioners share this view.

The leading OB-GYN organization has said paracetamol - the main ingredient in acetaminophen - is among limited choices for expectant mothers to treat pain and elevated temperature, which can create serious health risks if ignored.

"In more than two decades of studies on the consumption of paracetamol in gestation, no reliable research has definitively established that the usage of paracetamol in any stage of pregnancy results in neurological conditions in offspring," the association stated.

This legal action mentions recent announcements from the former administration in asserting the drug is allegedly unsafe.

In recent weeks, Trump generated worry from health experts when he instructed expectant mothers to "fight like hell" not to use Tylenol when unwell.

Federal regulators then released a statement that physicians should contemplate reducing the consumption of acetaminophen, while also declaring that "a causal relationship" between the medication and autism spectrum disorder in minors has not been proven.

Health Secretary RFK Jr, who manages the FDA, had pledged in spring to undertake "a massive testing and research effort" that would identify the cause of autism spectrum disorder in a limited time.

But authorities warned that discovering a unique factor of autism - considered by experts to be the result of a intricate combination of inherited and external influences - would be difficult.

Autism spectrum disorder is a category of enduring cognitive variation and impairment that affects how persons encounter and interact with the environment, and is recognized using doctors' observations.

In his lawsuit, Paxton - a Trump ally who is campaigning for the Senate - asserts Kenvue and Johnson & Johnson "willfully ignored and sought to suppress the evidence" around acetaminophen and autism.

The lawsuit aims to force the firms "remove any commercial messaging" that asserts Tylenol is safe for pregnant women.

The Texas lawsuit echoes the grievances of a group of parents of young ones with autism and attention deficit hyperactivity disorder who filed suit against the makers of acetaminophen in recently.

Judicial authorities dismissed the case, saying studies from the family's specialists was inconclusive.